Is a facelift possible after repeated facial filler injections?
Is a facelift possible after repeated facial filler injections?
People who have repeatedly received filler in the forehead, temples, anterior cheeks, nasolabial folds, or jawline often ask the following questions when considering a facelift.
“Does residual filler prevent me from having a facelift?” “Must all the filler be dissolved before surgery?” “Could filler make a facelift more difficult?”
A facelift can be possible even after repeated filler injections.
Previous filler treatment is not itself an absolute contraindication to a facelift.
However, the number of treatments is not the only important factor.
Preoperative assessment and planning may vary with the injected material, injection sites and tissue layers, amount remaining, and tissue changes such as edema, nodules, inflammation, or fibrosis.
Assessment after repeated filler treatment should therefore first distinguish volume from residual filler from actual soft-tissue sagging, rather than considering skin sagging alone.
Fillers and facelifts address different problems
Filler injections add volume to hollow areas or enhance facial contours.
A facelift, in contrast, repositions soft tissue and the SMAS layer that have descended with aging and removes excess skin as needed.
Their roles can be distinguished as follows.
- Filler: addresses hollowing and volume deficiency
- Facelift: corrects downward tissue displacement, including sagging cheeks, lower-cheek fullness, and loss of jawline definition
- Skin treatments: improve pigmentation, fine lines, pores, and skin surface changes
Fillers add volume but do not directly return descended tissues to their original position. Conversely, a facelift repositions sagging tissue and does not necessarily reduce all volume added by residual filler.
If the face looks heavy or enlarged after filler treatment, the following causes should first be distinguished.
- Residual filler or excessive volume from repeated injections
- Edema or inflammatory changes around filler
- Age-related sagging of the skin and SMAS
- Preexisting subcutaneous and deep fat
- Contributions from the salivary glands, muscles, or skeleton to
- facial contours
- Two or more coexisting issues
Repeated filler treatment does not make a facelift impossible
Repeated filler injections do not necessarily cause severe tissue damage or prevent a facelift.
A small amount injected into limited areas, without current edema, nodules, pain, or inflammation, may have little effect on standard facelift planning.
Even when filler remains, removal or dissolution is not necessarily required if it does not overlap the surgical area or interfere with contour assessment.
However, preoperative assessment can be more complex in some patients with the following histories or findings.
- Repeated high-volume injections into multiple facial areas
- An unknown filler type
- Different types of fillers or injectables
- Filler overlapping the planned surgical dissection plane
- Previous inflammation or nodules after filler treatment
- Firmness on palpation or restricted tissue mobility
- Filler obscuring the true degree of sagging and volume status
- Previous fat grafting or thread lifting as well
Repeated filler injections do not always alter normal tissue planes. However, when residual material overlaps the dissection plane, or previous inflammation, nodules, or fibrosis are present, distinguishing normal tissue planes may be more difficult and complicate planning and dissection.
Why filler can affect facelift planning
1. Filler may remain longer than expected
A reduction in the visible effect does not establish that the injected material has completely disappeared from the tissues.
Persistence varies with the product's composition and cross-linking, injected volume and location, tissue characteristics, and repeated treatment.
After multiple injections, filler may be distributed across different areas and tissue layers.
Residual filler may make it harder to assess underlying skeletal structure, fat distribution, true volume deficiency, and sagging.
If filler-supported volume present at surgery decreases over time, the postoperative balance of facial volume may also change.
2. Filler may mask true sagging
Repeated injections into the anterior cheeks, nasolabial folds, or jawline can temporarily fill hollows and make contours appear improved.
However, repeatedly filling hollows when tissue sagging has progressed can make the face look increasingly wide and heavy or create excessive projection in particular areas.
Distinguishing filler-created volume from actual tissue position is necessary to determine an accurate facelift extent.
3. Residual filler may become more noticeable after surgery
Repositioning tissues during a facelift may make previously inconspicuous filler borders or collections more visible afterward.
Filler in a superficial layer or unevenly concentrated in one area may cause a postoperative bulge or firmness on palpation.
Preoperative assessment should therefore include side views, changes with expression, and palpation, as well as the frontal appearance.
4. It may also affect fat-grafting plans
Residual filler must also be considered when planning fat grafting with a facelift.
Adding fat to an area with residual filler based only on its current hollow appearance can create excessive volume.
Conversely, if the graft volume is reduced to account for residual filler and the filler later decreases, volume deficiency may reappear.
Fat grafting after repeated filler treatment should therefore consider filler type, location, possible persistence, and long-term volume changes, rather than current hollowing alone.
Does repeated filler treatment increase facelift complications?
There are not yet enough comparative studies to draw a definitive conclusion.
In a 2023 survey of members of The Aesthetic Society, 51.9% of responding clinicians said that a history of repeated panfacial filler injections increased facelift difficulty.
This does not mean surgery was actually difficult in 51.9% of patients with previous filler.
It means that 51.9% of the responding clinicians judged, based on their clinical experience, that surgical difficulty had increased.
Limitations included a low response rate of 3.7% and the absence of a direct comparison of surgical outcomes between patients with repeated filler treatment and those without prior filler.
The authors also concluded that the actual effect of repeated filler on facelift complications and outcomes remained unclear and required objective prospective comparative research.
A subsequent single-center retrospective pilot study published in 2026 reported no major surgical complications associated with previous filler or biostimulatory injections and high patient satisfaction.
However, this study also had limitations in size and design and should not be interpreted as definitive evidence that repeated filler has no effect on facelift outcomes.
The available evidence can be summarized as follows.
There is no evidence that repeated filler injections make a facelift impossible. However, residual filler or tissue reactions may complicate assessment and planning in some patients, so individual evaluation is necessary.
Must all filler be dissolved before a facelift?
A history of filler treatment does not mean all filler must be dissolved before surgery.
A facelift may be performed with filler in place if it does not distort facial shape, cause problems such as edema or nodules, or directly overlap the surgical area.
Conversely, partial or staged dissolution of hyaluronic acid filler before surgery may be considered in the following situations.
- Excess filler makes true facial sagging difficult to assess
- Excessive projection of the anterior cheeks or nasolabial areas
- Asymmetry from filler concentrated on one side
- Recurrent edema around filler
- Superficial filler borders visible through the skin
- A substantial likelihood that residual filler will be more noticeable after surgery
- A need to establish the underlying volume before fat grafting with a facelift
The priority is selective assessment of filler that interferes with planning or causes deformity or symptoms, rather than automatically removing all filler.
When can a facelift be performed after filler dissolution?
No standard waiting period between preoperative hyaluronidase treatment and a facelift applies to every patient.
Temporary swelling, bruising, or tenderness may occur after hyaluronidase. As filler decreases, previously concealed hollowing, asymmetry, or tissue sagging may reappear.
Rather than determining facelift extent or fat-grafting volume immediately after dissolution, the following should be reassessed.
- Whether post-treatment swelling and inflammation have subsided
- Whether the underlying contours previously concealed by filler have become apparent
- Whether further dissolution is needed
- Whether remaining volume is filler or the patient's own fat
- The degree of skin and SMAS sagging
The clinical team should determine timing individually based on filler volume and location, number of dissolution sessions, tissue response, and surgical extent.
Can hyaluronidase dissolve every filler?
No. Hyaluronidase is an enzyme that breaks down hyaluronic acid fillers. Materials outside this category are not broken down in the same way.
Materials that hyaluronidase does not break down include the following.
- Calcium hydroxylapatite
- Poly-L-lactic acid
- PMMA
- Liquid silicone
- Paraffin
- Polyacrylamide hydrogel
- Other injectables of unknown composition
However, these materials should not all be regarded as “nondissolvable fillers” with identical properties.
Non-hyaluronic acid injectables differ in their mechanisms and tissue changes. Some materials or particles may remain in the tissues,
while biostimulators such as poly-L-lactic acid promote collagen production in surrounding tissue rather than directly filling volume like hyaluronic acid gel.
Inability to dissolve a product with hyaluronidase does not automatically make it an indication for surgical removal. The need for treatment should depend on composition, location, current symptoms, and surrounding tissue condition.
Might ultrasound be needed?
Not everyone with previous filler treatment needs ultrasound. A relatively clear treatment history and an unremarkable examination may allow planning based on history and palpation alone.
However, high-frequency ultrasound may help with assessment in the following situations.
- An unknown injected product
- Repeated filler injections into multiple facial areas
- Suspected filler accumulation on one side
- Palpable firm nodules or uneven areas
- Recurrent edema at the same location
- Persistent volume and deformity after hyaluronidase
- A need to determine whether filler location overlaps the surgical area
Ultrasound may help identify the location and distribution of suspected filler or foreign material and surrounding edema or nodules.
However, ultrasound alone cannot establish the product name or exact composition of every filler. Previous treatment records, palpation, and imaging findings must be interpreted together.
Can filler removal and a facelift be performed together?
This may be considered in selected situations depending on the patient, but filler removal is not a routine part of a facelift.
For hyaluronic acid filler, nonsurgical treatment with hyaluronidase is generally considered before surgical removal.
Searching for and removing all filler during a facelift is not a usual first-line treatment.
Surgery may be considered in limited situations such as the following.
- Suspected non-hyaluronic acid material or foreign material of unknown composition
- Firm nodules or granulomatous lesions
- Persistent pain, recurrent edema, or visible deformity
- Failure to improve with nonsurgical treatment
- A lesion overlapping the facelift surgical area
However, material spread through multiple layers around normal fat, muscle, and SMAS may not separate clearly from normal tissue. Excessive dissection in pursuit of complete removal may damage normal tissue, vessels, or nerves.
The goal is therefore to address symptom-causing and deforming material as far as feasible while preserving normal tissue, rather than removing every trace regardless of the consequences.
If the removal area differs from the facelift area or inflammation is active, the treatments may be staged rather than performed together.
What should be reviewed before a facelift after repeated filler treatment?
Even if you cannot remember every product name or dose, provide the clinical team with as much information as possible.
- Facial areas injected
- Dates of the first and most recent treatments
- Approximate number of treatments and injected volume
- Any remembered product names or filler types
- Previous hyaluronidase dissolution
- Edema, nodules, inflammation, or pain after filler
- Previous fat grafting or thread lifting
- Previous facial surgery
- Photographs and records from before and after previous treatments
It is especially important to disclose fat grafting or thread lifting performed in addition to filler.
Filler, grafted fat, threads, and surrounding fibrosis can each affect preoperative assessment and dissection differently.
Can a facelift make an enlarged face smaller?
A facelift is not a contour-reduction operation that narrows the facial bones or reduces the muscles themselves.
Repositioning sagging cheek and jawline tissues may refine the lower face and make it appear slimmer and more defined.
However, if residual filler, natural fat volume, muscle, salivary glands, or skeletal structure are the main reasons the face looks large, a facelift alone may not sufficiently reduce its apparent size.
When repeated filler injections have increased facial volume, facelift assessment and filler assessment should be conducted separately.
- Reposition sagging tissue with a facelift
- Dissolve excessive hyaluronic acid filler when needed
- Treat non-hyaluronic acid material or nodules separately according to their condition
- If fat is abundant, assess its layer and location before deciding on additional correction
It should therefore not be assumed that removing filler while lifting always makes the face smaller, or that a facelift alone reduces all excess volume.
Frequently asked questions
Q. Does repeated filler treatment prevent a facelift?
A. No. A history of repeated filler injections alone does not make a facelift impossible. However, assessment and technique may vary with filler type, location, amount remaining, and surrounding tissue condition.
Q. Must all filler always be dissolved before surgery?
A. No. Dissolution is considered selectively when residual filler distorts contours or interferes with planning. Asymptomatic filler outside the surgical area does not automatically need to be dissolved.
Q. If filler was injected long ago, hasn't it all disappeared?
A. Not necessarily. Some filler may remain in the tissues even after the visible effect diminishes. Repeated treatment or edema, nodules, or asymmetry may warrant examination and imaging when needed.
Q. Can I have a facelift immediately after dissolving filler?
A. No standard waiting period applies to every patient. Surgery should be timed after swelling and tissue reactions settle and underlying facial volume and sagging are reassessed.
Q. Can all filler be removed during a facelift?
A. Filler spread across multiple tissue layers may be difficult to remove completely and may not be distinguishable from normal tissue. Hyaluronic acid filler, in particular, is generally treated with hyaluronidase before surgical removal is considered.
Surgical removal is considered in limited situations, such as nondegradable foreign material or nodules.
Q. Does repeated filler necessarily increase facelift complications?
A. Current research cannot establish that it necessarily does.
Some physician surveys have reported increased surgical difficulty, but objective comparative patient data are limited. Previous filler history and current tissue condition should therefore be evaluated individually.
Current tissue condition matters more than the number of filler treatments
Repeated filler treatment alone is not a reason to give up on a facelift. However, it should not be dismissed as an insignificant past cosmetic treatment and left undisclosed to the clinical team.
Facelift assessment after repeated filler treatment should follow these steps.
- Identify what materials were previously injected and where.
- Distinguish residual filler volume from true tissue sagging.
- Assess edema, nodules, inflammation, and asymmetry.
- Use imaging such as ultrasound when needed.
- Determine whether preoperative dissolution or separate foreign-body treatment is needed.
- Plan facelift extent and dissection planes according to current tissue condition.
- Account for residual filler when deciding on additional volume correction such as fat grafting.
Facelift suitability is not determined solely by the number of filler treatments. It is important to distinguish filler-created volume, surrounding tissue changes, and true facial sagging, then plan treatment for each cause.
For questions about a facelift after repeated filler treatment, contact us at 02-545-3700 or through “UVOM Plastic Surgery” on KakaoTalk.